← Leaderboards
Gayatri Arun
Envisagenics, Inc.
$1,037,714
Attributed
$2,075,427
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2022–23$2M$1.5M$1M$500K$0
'22
'23
Funding mix
By agency
NIH$2,075,427 · 1
By mechanism
R44$2,075,427 · 1
Top collaborators
- Martin Akerman3 shared
Others in their field
Other Rising Stars on “Messenger Rna”
- Li Liang · University Of California-Irvine$7,511,446
- Bruxanne El-Kammash · University Of Chicago$7,281,050
- Victoria Coleman · Leidos Biomedical Research, Inc.$7,090,787
- Wendell Beres · Duke University$6,769,527
- Magnus Adrian Gero Hoffmann · California Institute Of Technology$5,819,250
- Lauren Carter · University Of Washington$5,637,003
Research focus
Messenger RnaNeoantigensImmunooncologyMedically Underserved AreaMutationMutation CarrierExome SequencingBrca GeneMalignant NeoplasmsMammaryAlternative SplicingCancer ImmunotherapeuticsBenignDeep SequencingBindingAutomobile DrivingCell SurfaceClinical CareBrca MutationsAntigensCommercializationBreastComputer SoftwareNovel Strategies
Grant awards (3)
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data$980,257
R44 · FY2023 · CA
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data$77,000
R44 · FY2023 · CA
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data$1,018,170
R44 · FY2022 · CA